GSTM1 null genotype in COPD and lung cancer: evidence of a modifier or confounding effect?
Robert P Young1,2, Raewyn J Hopkins1, Bryan A Hay1, Gregory D Gamble11Schools of Biological Science and Health Sciences, University of Auckland, 2Department of Medicine, Auckland City Hospital, Auckland, New ZealandBackground: Studies over the past two decades have reported associations between GSTM...
Main Authors: | Young RP, Hopkins RJ, Hay BA, Gamble GD |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-09-01
|
Series: | The Application of Clinical Genetics |
Online Access: | http://www.dovepress.com/gstm1-null-genotype-in-copd-and-lung-cancer-evidence-of-a-modifier-or--a8275 |
Similar Items
-
Genetic evidence linking lung cancer and COPD: a new perspective
by: Crapo JD, et al.
Published: (2011-07-01) -
GENOTYPE ASSOCIATION GSTM1 NULL AND GASTRIC CANCER: EVIDENCE-BASED META-ANALYSIS
by: Rívian Xavier RIBEIRO, et al.
Published: (2017-03-01) -
GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies
by: Shanli Li, et al.
Published: (2019-03-01) -
Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: an evidence-based meta-analysis.
by: Lin-Bo Gao, et al.
Published: (2011-01-01) -
GSTM1 null genotype and gastric cancer risk in the Chinese population: an updated meta-analysis and review
by: Zhang XL, et al.
Published: (2015-04-01)